FERROSAN INTERNATIONAL ApS - CVR: 45532410

2020, DKK

29.06.2021

Bruttoresultat

-120'

Primær drift

-120'

Årets resultat

-133'

Aktiver

8.779'

Kortfristede aktiver

8.779'

Egenkapital

8.698'

Afkastningsgrad

-1 %

Soliditetsgrad

99 %

Likviditetsgrad

+500%

Resultat

29.06.2021

Årsrapport	2020 29.06.2021	2018 02.09.2020	2017 03.05.2019	2016 30.04.2018	2015 02.05.2017
Nettoomsætning					19.683.000
Bruttoresultat	-120.000	-43.000	-540.000	-898.000	836.000
Resultat af primær drift	-120.000	-61.000	-561.000	-898.000	772.000
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0	0	0
Finansielle indtægter	4.000	0	-38.000	486.000	835.000
Finansieringsomkostninger	-17.000	-78.000	0	0	-581.000
Andre finansielle omkostninger	0	0	0	0	0
Resultat før skat	-133.000	-139.000	-599.000	-412.000	1.026.000
Resultat	-133.000	513.000	-594.000	-1.267.000	1.800.000
Forslag til udbytte	0	0	0	0	0

Aktiver

29.06.2021

Årsrapport	2020 29.06.2021	2018 02.09.2020	2017 03.05.2019	2016 30.04.2018	2015 02.05.2017
Kortfristede varebeholdninger	0	0	0	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	8.748.000	8.759.000	7.498.000	4.894.000	18.505.000
Likvider	31.000	72.000	820.000	4.342.000	685.000
Kortfristede aktiver	8.779.000	8.831.000	8.318.000	9.236.000	19.190.000
Immaterielle aktiver og goodwill	0	0	0	0	0
Finansielle anlægsaktiver	0	0	0	0	185.000
Materielle aktiver	0	0	0	0	0
Langfristede aktiver	0	0	0	0	185.000
Aktiver	8.779.000	8.831.000	8.318.000	9.236.000	19.375.000

Aktiver

29.06.2021

Passiver

29.06.2021

Årsrapport	2020 29.06.2021	2018 02.09.2020	2017 03.05.2019	2016 30.04.2018	2015 02.05.2017
Forslag til udbytte	0	0	0	0	0
Egenkapital	8.698.000	8.831.000	8.318.000	8.912.000	10.179.000
Hensatte forpligtelser	0	0	0	0	0
Langfristet gæld til banker	0	0	0	0	0
Anden langfristet gæld	0	0	0	0	0
Leverandører af varer og tjenesteydelser	0	0	0	0	0
Kortfristede forpligtelser	81.000	0	0	324.000	9.196.000
Gældsforpligtelser	0	0	0	324.000	9.196.000
Forpligtelser	0	0	0	324.000	9.196.000
Passiver	8.779.000	8.831.000	8.318.000	9.236.000	19.375.000

Passiver

29.06.2021

Nøgletal

29.06.2021

Årsrapport	2020 29.06.2021	2018 02.09.2020	2017 03.05.2019	2016 30.04.2018	2015 02.05.2017
Afkastningsgrad	-1,4 %	-0,7 %	-6,7 %	-9,7 %	4,0 %
Dækningsgrad	Na.	Na.	Na.	Na.	4,2 %
Resultatgrad	Na.	Na.	Na.	Na.	9,1 %
Varelagerets omsætningshastighed	Na.	Na.	Na.	Na.	Na.
Egenkapitals-forretning	-1,5 %	5,8 %	-7,1 %	-14,2 %	17,7 %
Payout-ratio	Na.	Na.	Na.	Na.	Na.
Gældsdæknings-nøgletal	-705,9 %	-78,2 %	Na.	Na.	132,9 %
Soliditestgrad	99,1 %	100,0 %	100,0 %	96,5 %	52,5 %
Likviditetsgrad	10.838,3 %	Na.	Na.	2.850,6 %	208,7 %

Resultat

29.06.2021

Gæld

29.06.2021

Årsrapport

29.06.2021

Nyeste:01.01.2020- 31.12.2020(offentliggjort: 29.06.2021)

Information om virksomhedens regnskabsklasse:The annual report of Ferrosan International ApS for 2020 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to reporting class B entities.

Beretning

29.06.2021

Dato for ledelsens godkendelse af årsrapporten:2021-06-11

Beskrivelse af usædvanlige forhold, der kan have påvirket indregningen eller målingen:Going concern GSK Group has considered any impact/strain on the central Treasury functions. We are confident the Group can continue to meet liquidity and working capital requirements whilst also not breaching any covenants. This is on the basis that there are currently no significant operational or contractual risks that would inhibit Treasury supporting local entities as they would under ‘normal’ conditions. The Company is supported financially by the GSK Group and has a credit facility at GlaxoSmithKline Consumer Healthcare Finance Ltd with no upper limit. GlaxoSmithKline Consumer Healthcare Finance Ltd has issued a letter of support to the Company that is valid for 12 months from the signing date of the financial statements for the year ended 31 December 2020. On the basis hereof, it is Management's assessment that the Company's financial resources are sufficient, and the financial statements are therefore prepared using the going concern assumption.

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Ferrosan International ApS for the financial year 1 January - 31 December 2020.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:Ferrosan International ApS is a part of the consumer healthcare joint venture between the British Glaxo Smith Kline-GSK and the American Pfizer group, both multinational pharmaceutical groups listed on the New York Stock Exchange. Ferrosan International ApS’ marketing activities for nutrition and pharmaceutical products on the international market outside Scandinavia, finalized in financial year 2015/16.